View Item 

Show simple item record

Individualized outcome prognostication for patients with laryngeal cancer

dc.contributor.authorHoban, Connor W.
dc.contributor.authorBeesley, Lauren J.
dc.contributor.authorBellile, Emily L.
dc.contributor.authorSun, Yilun
dc.contributor.authorSpector, Matthew E.
dc.contributor.authorWolf, Gregory T.
dc.contributor.authorTaylor, Jeremy M. G.
dc.contributor.authorShuman, Andrew G.
dc.date.accessioned2018-03-07T18:23:21Z
dc.date.available2019-04-01T15:01:09Zen
dc.date.issued2018-02-15
dc.identifier.citationHoban, Connor W.; Beesley, Lauren J.; Bellile, Emily L.; Sun, Yilun; Spector, Matthew E.; Wolf, Gregory T.; Taylor, Jeremy M. G.; Shuman, Andrew G. (2018). "Individualized outcome prognostication for patients with laryngeal cancer." Cancer 124(4): 706-716.
dc.identifier.issn0008-543X
dc.identifier.issn1097-0142
dc.identifier.urihttps://hdl.handle.net/2027.42/142424
dc.publisherEuropean Centre for Disease Prevention and Control (ECDC)
dc.publisherWiley Periodicals, Inc.
dc.subject.othercalculator
dc.subject.othernomogram
dc.subject.otherprognostication
dc.subject.otherrisk prediction
dc.subject.otherlarynx cancer
dc.titleIndividualized outcome prognostication for patients with laryngeal cancer
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelOncology and Hematology
dc.subject.hlbsecondlevelPublic Health
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/142424/1/cncr31087.pdf
dc.description.bitstreamurlhttps://deepblue.lib.umich.edu/bitstream/2027.42/142424/2/cncr31087_am.pdf
dc.identifier.doi10.1002/cncr.31087
dc.identifier.sourceCancer
dc.identifier.citedreferencePiccirillo JF, Lacy PD, Basu A, Spitznagel EL. Development of a new head and neck cancer‐specific comorbidity index. Arch Otolaryngol Head Neck Surg. 2002; 128: 1172 ‐ 1179.
dc.identifier.citedreferenceNolan T, Dack C, Pal K, et al. Patient reactions to a web‐based cardiovascular risk calculator in type 2 diabetes: a qualitative study in primary care. Br J Gen Pract. 2015; 65: e152 ‐ e160.
dc.identifier.citedreferenceKattan MW, Hess KR, Amin MB, et al. American Joint Committee on Cancer acceptance criteria for inclusion of risk models for individualized prognosis in the practice of precision medicine. CA Cancer J Clin. 2016; 66: 370 ‐ 374.
dc.identifier.citedreferenceEmerick KS, Leavitt ER, Michaelson JS, Diephuis B, Clark JR, Deschler DG. Initial clinical findings of a mathematical model to predict survival of head and neck cancer. Otolaryngol Head Neck Surg. 2013; 149: 572 ‐ 578.
dc.identifier.citedreferenceEgelmeer AG, Velazquez ER, de Jong JM, et al. Development and validation of a nomogram for prediction of survival and local control in laryngeal carcinoma patients treated with radiotherapy alone: a cohort study based on 994 patients. Radiother Oncol. 2011; 100: 108 ‐ 115.
dc.identifier.citedreferenceDatema FR, Ferrier MB, Vergouwe Y, et al. Update and external validation of a head and neck cancer prognostic model. Head Neck. 2013; 35: 1232 ‐ 1237.
dc.identifier.citedreferenceCollins GS, de Groot JA, Dutton S, et al. External validation of multivariable prediction models: a systematic review of methodological conduct and reporting [serial online]. BMC Med Res Methodol. 2014; 14: 40.
dc.identifier.citedreferencePrince V, Bellile EL, Sun Y, et al. Individualized risk prediction of outcomes for oral cavity cancer patients. Oral Oncol. 2016; 63: 66 ‐ 73.
dc.identifier.citedreferenceParks C, Heald J, Hall G, Kamaly‐Asl I. Can the prognosis of individual patients with glioblastoma be predicted using an online calculator? Neuro Oncol. 2013; 15: 1074 ‐ 1078.
dc.identifier.citedreferenceDuffy SA, Taylor JM, Terrell JE, et al. Interleukin‐6 predicts recurrence among head and neck cancer patients. Cancer. 2008; 113: 750 ‐ 757.
dc.identifier.citedreferenceVirani S, Bellile E, Bradford CR, et al. NDN and CD1A are novel prognostic methylation markers and differ by HPV status in patients with head and neck squamous carcinoma [serial online]. BMC Cancer. 2015; 15: 825.
dc.identifier.citedreferencePeterson LA, Bellile EL, Wolf GT, et al. University of Michigan Head and Neck Specialized Program of Research Excellence Program: cigarette use, comorbidities and prognosis in a prospective head and neck squamous cell carcinoma population. Head Neck Surg. 2016; 381810 ‐ 1820.
dc.identifier.citedreferenceWolf GT, Bellile E, Eisbruch A, et al. Survival rates using individualized bioselection treatment methods in patients with advanced laryngeal cancer. JAMA Otolaryngol Head Neck Surg. 2017; 143: 355 ‐ 366.
dc.identifier.citedreferenceHeagerty PJ, Lumley T, Pepe MS. Time‐dependent ROC curves for censored survival data and a diagnostic marker. Biometrics. 2000; 56: 337 ‐ 344.
dc.identifier.citedreferenceWang SJ, Wissel AR, Ord CB, et al. Individualized estimation of conditional survival for patients with head and neck cancer. Otolaryngol Head Neck Surg. 2011; 145: 71 ‐ 73.
dc.identifier.citedreferenceBlanchard P, Baujat B, Holostenco V, et al. Meta‐analysis of chemotherapy in head and neck cancer (MACH‐NC): a comprehensive analysis by tumour site. Radiother Oncol. 2011; 100: 33 ‐ 40.
dc.identifier.citedreferenceLewis CM, Weber RS. Standardizing treatment: a crisis in cancer care. Otolaryng Clin North Am. 2013; 46: 671 ‐ 679.
dc.identifier.citedreferenceBlayney DW, McNiff K, Eisenberg PD, et al. Development and future of the American Society of Clinical Oncology’s Quality Oncology Practice Initiative. J Clin Oncol. 2014; 32: 3907 ‐ 3913.
dc.identifier.citedreferenceLewis CM, Weber RS, Hanna EY. Quality of care in head and neck cancer. Curr Oncol Rep. 2011; 13: 120 ‐ 125.
dc.identifier.citedreferenceGraboyes EM, Townsend ME, Kallogjeri D, Piccirillo JF, Nussenbaum B. Evaluation of quality metrics for surgically treated laryngeal squamous cell carcinoma. JAMA Otolaryngol Head Neck Surg. 2016; 142: 1154 ‐ 1163.
dc.identifier.citedreferenceForastiere AA, Weber RS, Trotti A. Organ preservation for advanced larynx cancer: issues and outcomes. J Clin Oncol. 2015; 33: 3262 ‐ 3268.
dc.identifier.citedreferenceRoman BR, Awad MI, Patel SG. Defining value‐driven care in head and neck oncology [serial online]. Curr Oncol Rep. 2015; 17: 424.
dc.identifier.citedreferenceShellenberger TD, Madero‐Visbal R, Weber RS. Quality indicators in head and neck operations: a comparison with published benchmarks. Arch Otolaryngol Head Neck Surg. 2011; 137: 1086 ‐ 1093.
dc.identifier.citedreferenceBegg CB, Cramer LD, Hoskins WJ, Brennan MF. Impact of hospital volume on operative mortality for major cancer surgery. JAMA. 1998; 280: 1747 ‐ 1751.
dc.identifier.citedreferenceDudley RA, Johansen KL, Brand R, Rennie DJ, Milstein A. Selective referral to high‐volume hospitals: estimating potentially avoidable deaths. JAMA. 2000; 283: 1159 ‐ 1166.
dc.identifier.citedreferenceBirkmeyer JD, Siewers AE, Finlayson EVA, et al. Hospital volume and surgical mortality in the United States. N Engl J Med. 2002; 346: 1128 ‐ 1137.
dc.identifier.citedreferenceFakhry C, Westra WH, Wang SJ, et al. The prognostic role of sex, race, and human papillomavirus in oropharyngeal and nonoropharyngeal head and neck squamous cell cancer. Cancer. 2017; 123: 1566 ‐ 1575.
dc.identifier.citedreferenceMeldolesi E, van Soest J, Damiani A, et al. Standardized data collection to build prediction models in oncology: a prototype for rectal cancer. Future Oncol. 2016; 12: 119 ‐ 136.
dc.identifier.citedreferenceSiegel R, Miller K, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015; 65: 5 ‐ 29.
dc.identifier.citedreferenceHutcheson KA, Lewin JS. Functional outcomes after chemoradiotherapy of laryngeal and pharyngeal cancers. Curr Oncol Rep. 2012; 14: 158 ‐ 165.
dc.identifier.citedreferenceForastiere AA, Zhang Q, Weber RS, et al. Long‐term results of RTOG 91‐11: a comparison of 3 nonsurgical treatment strategies to preserve the larynx in patients with locally advanced larynx cancer. J Clin Oncol. 2013; 31: 845 ‐ 852.
dc.identifier.citedreferenceWorden FP, Kumar B, Lee JS, et al. Chemoselection as a strategy for organ preservation in advanced oropharynx cancer: response and survival positively associated with HPV16 copy number. J Clin Oncol. 2008; 26: 3138 ‐ 3146.
dc.identifier.citedreferenceTerrell JE, Fisher SG, Wolf GT. Long‐term quality of life after treatment of laryngeal cancer. Arch Otolaryngol. 1998; 124: 964 ‐ 971.
dc.identifier.citedreferenceAmin MB, Greene FL, Edge SB, et al. The 8th ed. AJCC Cancer Staging Manual: continuing to build a bridge from a population‐based to a more “personalized” approach to cancer staging. CA Cancer J Clin. 2017; 67: 93 ‐ 99.
dc.identifier.citedreferenceBilimoria KY, Stewart AK, Winchester DP, Ko CY. The National Cancer Data Base: a powerful initiative to improve cancer care in the United States. Ann Surg Oncol. 2008; 15: 683 ‐ 690.
dc.identifier.citedreferenceBradford CR, Kumar B, Bellile E, et al. Biomarkers in advanced larynx cancer. Laryngoscope. 2014; 124: 179 ‐ 187.
dc.identifier.citedreferenceStarska K, Forma E, Jozwiak P, et al. Gene and protein expression of glucose transporter 1 and glucose transporter 3 in human laryngeal cancer—the relationship with regulatory hypoxia‐inducible factor‐1α expression, tumor invasiveness, and patient prognosis. Tumor Biol. 2015; 36: 2309 ‐ 2321.
dc.identifier.citedreferenceWolf GT, Hong WK, Fisher SG, et al. induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991; 324: 1685 ‐ 1690.
dc.identifier.citedreferenceLefebvre JL, Andry G, Chevalier D, et al. Laryngeal preservation with induction chemotherapy for hypopharyngeal squamous cell carcinoma: 10‐year results of EORTC trial 24891. Ann Oncol. 2012; 23: 2708 ‐ 2714.
dc.identifier.citedreferenceCalais G, Pointreau Y, Alfonsi M, et al. Randomized phase III trial comparing induction chemotherapy using cisplatin (P) fluorouracil (F) with or without docetaxel (T) for organ preservation in hypopharynx and larynx cancer. Preliminary results of GORTEC 2000‐01 [abstract]. J Clin Oncol. 2006; 24 ( 18 suppl ). Abstract 5506.
dc.identifier.citedreferenceLonning PE. Breast cancer prognostication and prediction: are we making progress? Ann Oncol. 2007; 18 ( suppl 8 ): viii3 ‐ viii7.
dc.identifier.citedreferenceVuralkan E, Akin I, Kuran G, Saka C, Akcayoz N, Alicura S. Prognostic factors in larynx cancers. Kulak Burun Bogaz Ihtis Derg. 2008; 18: 221 ‐ 226.
dc.identifier.citedreferenceSobin LH. TNM. evolution and relation to other prognostic factors. Semin Surg Oncol. 2003; 21: 3 ‐ 7.
dc.identifier.citedreferenceRabin B, Gaglio B, Sanders T, et al. Predicting cancer prognosis using interactive online tools: a systematic review and implications for cancer care providers. Cancer Epidemiol Biomarkers Prev. 2013; 22: 1645 ‐ 1656.
dc.identifier.citedreferenceRoss PL, Gerigk C, Gonen M, et al. Comparisons of nomograms and urologists’ predictions in prostate cancer. Semin Urol Oncol. 2002; 20: 82 ‐ 88.
dc.identifier.citedreferenceMackillop WJ, Quirt CF. Measuring the accuracy of prognostic judgments in oncology. J Clin Epidemiol. 1997; 50: 21 ‐ 29.
dc.identifier.citedreferenceGorlia T, Wu W, Wang M, et al. New validated prognostic models and prognostic calculators in patients with low‐grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials. Neuro Oncol. 2013; 15: 1568 ‐ 1579.
dc.identifier.citedreferenceHesse BW, Moser RP, Rutten LJ. Surveys of physicians and electronic health information. N Engl J Med. 2010; 362: 859 ‐ 860.
dc.identifier.citedreferenceKreps GL, Neuhauser L. New directions in eHealth communication: opportunities and challenges. Patient Educ Couns. 2010; 78: 329 ‐ 336.
dc.identifier.citedreferenceHiggins O, Sixsmith J, Barry MM, Domegan C. A Literature Review on Health Information‐Seeking Behaviour on the Web: A Health Consumer and Health Professional Perspective. Insights into Health Communication. Stockholm, Sweden: European Centre for Disease Prevention and Control (ECDC); 2011. Available at: https://ecdc.europa.eu/sites/portal/files/media/en/publications/Publications/Literature%20review%20on%20health%20information-seeking%20behaviour%20on%20the%20web.pdf. Accessed February 14, 2017.
dc.identifier.citedreferenceMcClymont K, Lee S, Schonberg M, Widera E, Miao Y, Smith AK. Usefulness and impact of online prognostic calculators. J Am Geriatr Soc. 2014; 62: 2444 ‐ 2445.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
cncr31087.pdf
Size:
692.2KB
Format:
PDF
View/Open
Name:
cncr31087_am.pdf
Size:
981.1KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.